Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

The Depressive and Suicide Disorders Program is a superspecialized (third-line) service for youth and adults who suffer from refractory and/or recurrent major depressive disorder with or without the presence of suicidal behaviour. The program offers cutting-edge treatment for clients and provides support to families to help them interact with the person in difficulty.

The Severe Disruptive Disorders Program offers a range of superspecialized services for children aged 6 to 12 years with behaviour problems with or without an attention deficit disorder / hyperactivity disorder (ADHD).

Eduardo Chachamovich’s work focuses mainly on social and clinical determinants of mental health in Aboriginal populations.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.

Ashok Malla is an international leader in the development of programs for, and research in, early intervention in psychosis.

Patricia Boksa conducts research on pregnancy and birth complications as risk factors for the later development of schizophrenia.

Norbert Schmitz is involved in biostatistics, psychiatric epidemiology and psychometrics.  

Jens Pruessner uses brain imaging techniques to investigate what happens in the brain when stress is perceived and processed.

Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.